Trial Profile
A Phase I Study of ABT-888 in Combination With Topotecan Hydrochloride in Adults With Refractory Solid Tumors and Lymphomas.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Topotecan (Primary) ; Veliparib (Primary)
- Indications Chronic lymphocytic leukaemia; Lymphoma; Solid tumours
- Focus Adverse reactions; Biomarker
- 18 Oct 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 18 Oct 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 18 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (NCT00553189).